Apr 21, 2025 | Case Study, Case Study Forecasting, Case Study Portfolio
The oncology team of a major multinational pharmaceutical company asked Ozmosi to provide additional forecasting support for a newly acquired product. They needed to update and validate the current forecast models to identify the most effective development strategies...
Apr 21, 2025 | Case Study, Market Scan
A regional marketing team for a multinational pharmaceutical company needed a complete market overview of a neuroscience therapy area within the Asia Pacific region. This overview had both internal and external perspectives covering the science, competitive and...
Apr 21, 2025 | Business, Chronic Disease, Diabetes, Disease Area Trends
For years, Eli Lilly’s main contributions to the Diabetes market were their insulins: fast-acting analog Humalog® and human insulin Humalin and two premix offerings in analog Humalog® Mix 50/50 and human premix Humalin 75/25. Despite a legacy category, this portfolio...
Apr 21, 2025 | Case Study, Case Study Forecasting
The Children’s Hospital of Philadelphia–Policy Lab approached Ozmosi for help in supporting its application for federal funding to establish a new organizational structure to better support children in the Philadelphia foster care system. The proposed structure was...
Apr 21, 2025 | Case Study, Case Study Portfolio
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio, its leaders turned to Ozmosi for a complete, bottom-up portfolio management solution. The company was missing key data for many of its...
